OrthoPediatrics Corp. (NASDAQ:KIDS) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• OrthoPediatrics Corp. has received a consensus rating of "Moderate Buy" from analysts, with an average price target of $34.14 among the eight brokerages covering the stock.
• Insider trading activity includes CFO Fred Hite purchasing 5,076 shares at an average cost of $19.41 per share, increasing their ownership stake in the company.
• For its recent quarter, OrthoPediatrics reported earnings of ($0.11) per share, beating expectations, but noted a negative net margin of 18.92%.

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) have been given an average recommendation of "Moderate Buy" by the eight brokerages that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $34.1429.

KIDS has been the topic of several recent research reports. Citigroup reissued a "market outperform" rating on shares of OrthoPediatrics in a research note on Friday, August 8th. Wall Street Zen upgraded OrthoPediatrics from a "sell" rating to a "hold" rating in a report on Saturday, August 9th. BTIG Research reduced their price target on OrthoPediatrics from $40.00 to $39.00 and set a "buy" rating on the stock in a report on Wednesday, August 6th. Finally, JMP Securities set a $35.00 price target on shares of OrthoPediatrics and gave the company a "market outperform" rating in a research report on Friday, August 8th.

Insider Activity at OrthoPediatrics

In other OrthoPediatrics news, CFO Fred Hite acquired 5,076 shares of the business's stock in a transaction that occurred on Thursday, August 21st. The stock was purchased at an average cost of $19.41 per share, with a total value of $98,525.16. Following the transaction, the chief financial officer owned 213,065 shares of the company's stock, valued at $4,135,591.65. This trade represents a 2.44% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. 31.80% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On OrthoPediatrics

A number of hedge funds have recently made changes to their positions in the stock. Northern Trust Corp lifted its stake in OrthoPediatrics by 0.3% during the 4th quarter. Northern Trust Corp now owns 193,798 shares of the company's stock worth $4,492,000 after acquiring an additional 644 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new stake in OrthoPediatrics during the fourth quarter worth about $461,000. Deutsche Bank AG lifted its position in shares of OrthoPediatrics by 57.1% during the fourth quarter. Deutsche Bank AG now owns 14,393 shares of the company's stock worth $334,000 after purchasing an additional 5,233 shares in the last quarter. Millennium Management LLC purchased a new position in shares of OrthoPediatrics in the fourth quarter valued at approximately $9,798,000. Finally, OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of OrthoPediatrics by 25.5% in the fourth quarter. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 65,292 shares of the company's stock valued at $1,513,000 after purchasing an additional 13,270 shares in the last quarter. Hedge funds and other institutional investors own 69.05% of the company's stock.

OrthoPediatrics Stock Down 2.0%

KIDS opened at $20.49 on Wednesday. The company has a fifty day moving average of $21.05 and a two-hundred day moving average of $21.94. The company has a debt-to-equity ratio of 0.27, a quick ratio of 3.43 and a current ratio of 6.66. OrthoPediatrics has a fifty-two week low of $16.59 and a fifty-two week high of $33.14. The stock has a market capitalization of $513.68 million, a price-to-earnings ratio of -11.45 and a beta of 1.06.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.17) by $0.06. The firm had revenue of $61.08 million for the quarter, compared to analysts' expectations of $61.40 million. OrthoPediatrics had a negative net margin of 18.92% and a negative return on equity of 6.36%. OrthoPediatrics has set its FY 2025 guidance at EPS. On average, research analysts expect that OrthoPediatrics will post -0.93 earnings per share for the current year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.